These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
439 related items for PubMed ID: 18609067
1. Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease. Das KS, Balakrishnan V, Mukherjee S, Vasudevan DM. Scand J Clin Lab Invest; 2008; 68(4):323-34. PubMed ID: 18609067 [Abstract] [Full Text] [Related]
2. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A. J Clin Gastroenterol; 2006; 40(10):930-5. PubMed ID: 17063114 [Abstract] [Full Text] [Related]
3. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Videla LA, Rodrigo R, Orellana M, Fernandez V, Tapia G, Quiñones L, Varela N, Contreras J, Lazarte R, Csendes A, Rojas J, Maluenda F, Burdiles P, Diaz JC, Smok G, Thielemann L, Poniachik J. Clin Sci (Lond); 2004 Mar; 106(3):261-8. PubMed ID: 14556645 [Abstract] [Full Text] [Related]
4. Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. Perlemuter G, Davit-Spraul A, Cosson C, Conti M, Bigorgne A, Paradis V, Corre MP, Prat L, Kuoch V, Basdevant A, Pelletier G, Oppert JM, Buffet C. Liver Int; 2005 Oct; 25(5):946-53. PubMed ID: 16162151 [Abstract] [Full Text] [Related]
5. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin. Samy W, Hassanian MA. Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478 [Abstract] [Full Text] [Related]
6. Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease? Canbakan B, Senturk H, Canbakan M, Toptas T, Tabak O, Balci H, Olgac V, Ozbay G. Biomark Med; 2010 Apr; 4(2):205-14. PubMed ID: 20406065 [Abstract] [Full Text] [Related]
7. Plasma reactive carbonyl species levels and risk of non-alcoholic fatty liver disease. Liu S, Shi W, Li G, Jin B, Chen Y, Hu H, Liu L, Xie F, Chen K, Yin D. J Gastroenterol Hepatol; 2011 Jun; 26(6):1010-5. PubMed ID: 21265881 [Abstract] [Full Text] [Related]
8. Blood oxidative stress markers are unreliable markers of hepatic steatosis. Bonnefont-Rousselot D, Ratziu V, Giral P, Charlotte F, Beucler I, Poynard T, Lido Study Group. Aliment Pharmacol Ther; 2006 Jan 01; 23(1):91-8. PubMed ID: 16393285 [Abstract] [Full Text] [Related]
9. Hepatoprotective effect of chrysin on prooxidant-antioxidant status during ethanol-induced toxicity in female albino rats. Sathiavelu J, Senapathy GJ, Devaraj R, Namasivayam N. J Pharm Pharmacol; 2009 Jun 01; 61(6):809-17. PubMed ID: 19505373 [Abstract] [Full Text] [Related]
13. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C]. Pár A, Róth E, Rumi G, Kovács Z, Nemes J, Mózsik G. Orv Hetil; 2000 Jul 23; 141(30):1655-9. PubMed ID: 10962902 [Abstract] [Full Text] [Related]
15. Plasma interleukin-18/interleukin-18 binding protein ratio in Chinese with NAFLD. Li Y, Li-Li Z, Qin L, Ying W. Hepatogastroenterology; 2010 Jul 23; 57(97):103-6. PubMed ID: 20422882 [Abstract] [Full Text] [Related]